Nat Goodman has left his position as senior vice president at bioinformatics consulting firm 3rd Millennium. Goodman, who writes the monthly IT Guy column for BioInforms sister publication, Genome Technology magazine, plans to relocate to the Seattle area in the next few months. During the transition, he expects to spend most of his time doing pro bono work on Huntingtons disease and working on a writing project for Cambridge Healthtech Institute on microarray informatics.
Goodmans move is the third in a series of departures from 3rd Millennium in recent months. Previously, Eric Neumann left the company and joined Beyond Genomics, and Joanne Luciano departed to her own company Predictive Medicine.
Silicon Genetics has hired Deepak Thakkar as senior director of marketing. Thakkar was most recently director of product management and market development at Merck subsidiary Rosetta Inpharmatics.
David Carlin was promoted to vice president and group leader of biostatistics and data management at MedImmune, one of six recent promotions and new appointments at the company.
Carlin joined MedImmune in 1995 from Otsuka America Pharmaceutical, where he served as director of biostatistics and data/information systems.
Joseph Lehnen, who led InforMax through a successful IPO last year and raised a total of $120 million in financing for the company, will now serve as chief financial officer at clinical-stage biotechnology company TheraMed.